Why are you reporting this TALK?
tovecimig meets primary endpoint in BTC
Daniel AhnVisit
investors.compasstherapeutics.com
to learn moreApril 2, 2025
11 hr
Channels
DiscoveryCardiologyCOVIDDermatologyEndocrinologyGastroenterologyHematologyHepatologyNephrologyNeurologyOncologyOphthalmologyEvery DayAMDDry Eye DiseaseEyeCan: A Canadian Lens on OphthalmologyVISIONS 2024ARVO 2024AAO 2023WIO 2022
Primary CarePulmonologyRheumatologyUrologyDescription
tovecimig meets primary endpoint in BTC